Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.10M | -2.05M | -1.79M | -1.53M | -2.26M |
| Total Depreciation and Amortization | 79.80K | 101.40K | 98.80K | 96.10K | 93.10K |
| Total Amortization of Deferred Charges | 290.60K | 286.50K | 231.40K | 184.50K | 153.80K |
| Total Other Non-Cash Items | -736.50K | 284.50K | 359.20K | 360.10K | 1.20M |
| Change in Net Operating Assets | 381.40K | 210.90K | -22.20K | 33.40K | 162.90K |
| Cash from Operations | -1.09M | -1.16M | -1.12M | -852.50K | -657.70K |
| Capital Expenditure | 0.00 | -26.10K | -26.10K | -26.10K | -26.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -25.00K | -25.00K | -16.70K | 17.30K | 41.30K |
| Cash from Investing | -25.00K | -51.10K | -42.80K | -8.80K | 15.20K |
| Total Debt Issued | 1.59M | 1.72M | 1.73M | 1.57M | 1.24M |
| Total Debt Repaid | -469.90K | -526.20K | -558.80K | -630.20K | -584.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.12M | 1.19M | 1.17M | 940.40K | 656.40K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.00K | -24.30K | 3.50K | 79.00K | 13.80K |